Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-04-11
1996-01-23
Chang, Ceila
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142382, 514255, 514318, 514422, 514428, 514640, 544124, 544146, 544162, 544364, 544398, 546192, 546193, 546212, 546214, 546232, 546338, 548566, 548569, 562517, 562595, 564114, 564256, A61K 3115, C07C25148
Patent
active
054865280
ABSTRACT:
Novel basic ether of general formula (I), ##STR1## wherein R.sup.1 and R.sup.2 are independently hydrogen, halogen or C.sub.1-4 alkoxy, or together they represent a 3,4-methylenedioxy group,
REFERENCES:
patent: 5166416 (1992-11-01), Congy
patent: 5378716 (1995-01-01), Hamanaka
Uuterhalt et al "Kurzmitteilungen. Ungesattigtte Oxime" Arch Pharm. 316 469-471 (1983).
Congy et al "Biochemical & Pharmacological Properties of SR 46349B" J. Pha. Exp. Ther. 262 759-768 (1992).
Bajnogel Judit
Blasko Gabor
Budai Zoltan
Egyed Andras
Fekete Marton
Chang Ceila
Egis Gyogyszergyar Rt.
LandOfFree
Basic ethers and process for the preparation thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Basic ethers and process for the preparation thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Basic ethers and process for the preparation thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1505238